Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Revenue projections:
Revenue projections for ANURAS The projected decline in ANURAS's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.
Financial Ratios:
currentRatio
0.00000
forwardPE
51.49328
debtToEquity
44.56600
earningsGrowth
7.61100
revenueGrowth
0.91100
grossMargins
0.55283
operatingMargins
0.19267
trailingEps
11.27000
forwardEps
21.98000
Anupam Rasayan India Ltd's forward PE ratio being too high suggests the stock's future gains could be limited, with a potential for price correction. It's critical to weigh this alongside other key fundamental parameters for a comprehensive assessment. ANURAS's positive earnings and revenue growth suggest that the company is expected to expand its business. This reflects a healthy financial outlook, as ANURAS's increasing profits and sales signal further growth in the near future. ANURAS's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting ANURAS to generate stronger earnings compared to the previous financial year.
Price projections:
Price projections for ANURAS Over time, price projections for ANURAS have gradually increased, reflecting rising confidence in the company's future performance. This upward trend suggests analysts expect ANURAS to continue on a positive growth trajectory.
Recommendation changes over time:
Recommendations trend for ANURAS
ANURAS has received no definitive buy or sell ratings from analysts, presenting a mixed outlook for the stock. This uncertainty could leave investors hesitant, prompting them to consider other market indicators before making any investment decisions.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
The article discusses the implications of the Eurozone CPI at 2.1% regarding...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.